Acute, Multiple-Dose Dermal And Genetic Toxicity Of Nu-3: A Novel Antimicrobial Agent
UTSePress Research/Manakin Repository
JavaScript is disabled for your browser. Some features of this site may not work without it.
- UTSePress Research Home
- >
- 10 Technology
- >
- Journal Articles
- >
- Closed
- >
- View Item
| dc.contributor.author | Sun Jigui | en_US |
| dc.contributor.author | Hu Y.J | en_US |
| dc.contributor.author | Cao Sp | en_US |
| dc.contributor.author | Zhang Guangquan | en_US |
| dc.contributor.author | Sun Lun-Quan | en_US |
| dc.contributor.author | Wang Mei | en_US |
| dc.contributor.editor | en_US | |
| dc.date.accessioned | 2011-02-07T06:23:54Z | |
| dc.date.available | 2011-02-07T06:23:54Z | |
| dc.date.issued | 2010 | en_US |
| dc.identifier | 2009008467 | en_US |
| dc.identifier.citation | Sun Jigui et al. 2010, 'Acute, Multiple-Dose Dermal And Genetic Toxicity Of Nu-3: A Novel Antimicrobial Agent', Hindawi Publishing Corporation, vol. 2010, no. NA, pp. 1-8. | en_US |
| dc.identifier.issn | 1110-7243 | en_US |
| dc.identifier.other | C1 | en_US |
| dc.identifier.uri | http://hdl.handle.net/10453/13696 | |
| dc.description.abstract | Nu-3 [butyl-phosphate-5'-thymidine-3'-phosphate-butyl] is a modified nucleotide that has been shown to have antimicrobial activity against a range of bacteria including Pseudomonas aeruginosa. However, data on the toxicological profile of Nu-3 are still | en_US |
| dc.language | en_US | |
| dc.publisher | Hindawi Publishing Corporation | en_US |
| dc.relation.isbasedon | http://dx.doi.org/10.1155/2010/362524 | en_US |
| dc.title | Acute, Multiple-Dose Dermal And Genetic Toxicity Of Nu-3: A Novel Antimicrobial Agent | en_US |
| dc.parent | Journal Of Biomedicine And Biotechnology | en_US |
| dc.journal.volume | 2010 | en_US |
| dc.journal.number | NA | en_US |
| dc.publocation | New York | en_US |
| dc.identifier.startpage | 1 | en_US |
| dc.identifier.endpage | 8 | en_US |
| dc.cauo.name | FEIT.School of Systems, Management and Leadership | en_US |
| dc.conference | Verified OK | en_US |
| dc.for | 100400 | en_US |
| dc.personcode | 0000050076;0000049298;0000064475;020014;104335;0000021071 | en_US |
| dc.percentage | 000100 | en_US |
| dc.classification.name | Medical Biotechnology | en_US |
| dc.classification.type | FOR-08 | en_US |
| dc.edition | en_US | |
| dc.custom | en_US | |
| dc.date.activity | en_US | |
| dc.location.activity | ISI:000281300400001 | en_US |
| dc.description.keywords | Cho-Hgprt System; Resistant Pseudomonas-Aeruginosa; Intensive-Care Units; Beta-Lactamase; Burn Unit; Outbreak; Assay | en_US |
| dc.staffid | Kang Na Hsiung Enterprise Co Ltd;Daqing Petroleum Institute | en_US |
